NCT05456763View on ClinicalTrials.gov

Butyrate in Pediatric Inflammatory Bowel Disease

NACompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

June 30, 2013

Primary Completion Date

February 29, 2016

Study Completion Date

June 30, 2022

Conditions
Inflammatory Bowel Diseases
Interventions
DIETARY_SUPPLEMENT

sodium butyrate

add-on therapy irrespective of standard treatment depending on severity (according to the guidelines)

OTHER

placebo

placebo

All Listed Sponsors
lead

Centre of Postgraduate Medical Education

OTHER

NCT05456763 - Butyrate in Pediatric Inflammatory Bowel Disease | Biotech Hunter | Biotech Hunter